EUVIMEDEUVIMED entdecken
Systematische ÜbersichtOpen Access · CC BY 4.0

Reaching the therapeutic ceiling in IBD: Can Advanced Combination Treatment (ACT) offer a solution?

Virginia Solitano, Jurij Hanžel, Maria Manuela Estevinho, Rocio Sedano, Luca Massimino, Federica Ungaro, Vipul Jairath

Best Practice & Research Clinical Gastroenterology · 2025

DOI: 10.1016/j.bpg.2025.101981 ↗

Kurz gefasst

Systematische Übersicht in der Zeitschrift Best Practice & Research Clinical Gastroenterology, 2025. Verfasst von Virginia Solitano und 6 weiteren Autor:innen. Beteiligte Einrichtung: Division of Gastroenterology and Gastrointestinal Endoscopy, IRCCS Ospedale San Raffaele, Università Vita-Salute San Raffaele, Milan, Italy; Division…. Hauptthemen laut MEDLINE: Biological Products, Gastrointestinal Agents, Inflammatory Bowel Diseases. Die Arbeit wurde bisher 22-mal zitiert (Crossref) und nennt 32 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The term Advanced Combination Treatment (ACT) involves the combination of at least two biologics or the use of a biologic with a small molecule drug, each with different mechanisms of action. This narrative review evaluates the current evidence supporting ACT in inflammatory bowel disease (IBD), focusing on preclinical studies, real-world evidence, and randomized controlled trials. A systematic review of randomized controlled trials has concluded that ACT significantly improves clinical outcomes, without significant safety concerns in patient with IBD. However, variability in trial designs and the lack of standardized outcome measures have led to initiatives aimed at mitigating these issues through a clear expert consensus. While the evidence for ACT in IBD is compelling, substantial challenges remain in standardizing treatment protocols and ensuring long-term safety. In the meantime, the use of ACT in clinical practice remains off-label and requires careful consideration of patient-specific factors. Future clinical trials should consider robust biomarkers for patient selection and leverage mechanistic insights to select combination components.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Biological ProductsGastrointestinal AgentsInflammatory Bowel DiseasesHumansDrug Therapy, CombinationRandomized Controlled Trials as TopicTreatment Outcome

Stichwörter der Autor:innen

Crohn's diseaseDualImmune-mediated inflammatory diseasesTherapeutic ceilingUlcerative colitis

Substanzen

Biological ProductsGastrointestinal Agents

Autor:innen und Institutionen

  • Division of Gastroenterology and Gastrointestinal Endoscopy, IRCCS Ospedale San Raffaele, Università Vita-Salute San Raffaele, Milan, Italy; Division of Gastroenterology, Department of Medicine, Western University Schul…
  • Medical Faculty, University of Ljubljana, Department of Gastroenterology, UMC Ljubljana, Ljubljana, Slovenia.
  • Department of Gastroenterology, Unidade Local de Saúde Gaia Espinho (ULSGE), Vila Nova de Gaia, Portugal; Department of Biomedicine, Unit of Pharmacology and Therapeutics, Faculty of Medicine, University of Porto, Porto…
  • Division of Gastroenterology, Department of Medicine, Western University Schulich School of Medicine, London, Ontario, Canada.
  • Division of Gastroenterology and Gastrointestinal Endoscopy, IRCCS Ospedale San Raffaele, Università Vita-Salute San Raffaele, Milan, Italy.
  • Division of Gastroenterology, Department of Medicine, Western University Schulich School of Medicine, London, Ontario, Canada; Department of Epidemiology and Biostatistics, Western University, London, Ontario, Canada. E…

Zitieren

APA

Solitano, V., Hanžel, J., Estevinho, M. M., Sedano, R., Massimino, L., Ungaro, F., & Jairath, V. (2025). Reaching the therapeutic ceiling in IBD: Can Advanced Combination Treatment (ACT) offer a solution?. Best Practice & Research Clinical Gastroenterology. https://doi.org/10.1016/j.bpg.2025.101981

Vancouver

Solitano V, Hanžel J, Estevinho MM, Sedano R, Massimino L, Ungaro F, et al. Reaching the therapeutic ceiling in IBD: Can Advanced Combination Treatment (ACT) offer a solution?. Best Practice & Research Clinical Gastroenterology. 2025. doi:10.1016/j.bpg.2025.101981

BibTeX
@article{Solitano2025,
  author = {Solitano, Virginia and Hanžel, Jurij and Estevinho, Maria Manuela and Sedano, Rocio and Massimino, Luca and Ungaro, Federica and Jairath, Vipul},
  title = {Reaching the therapeutic ceiling in IBD: Can Advanced Combination Treatment (ACT) offer a solution?},
  journal = {Best Practice & Research Clinical Gastroenterology},
  year = {2025},
  doi = {10.1016/j.bpg.2025.101981}
}
Kostenlos starten →